Regulations regarding Fees Payable in terms of the provisions of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965), 2020
Purchase cart Previous page Return to chapter overview Next page

 

Notice No. R. 1379 of 2020

1. Definitions

2. Fees

3. Fees for Clinical Trials

4. Fee for New Licences

5. Fees for Inspections to assess the quality, safety and efficacy of medicines or scheduled substances

6. Fees for Permits and Certificates

7. Amendment of entries in Register

8. Transfer of Certificates of Registration

9. Appeal against the decision of the Authority

10. Repeal of Laws

11. Short Title